CVS Group (CVSG)

Sector:

Retailers

Index:

FTSE AIM 50

 818.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,704.00p
  • 52 Week Low: 798.00p
  • Currency: UK Pounds
  • Shares Issued: 71.74m
  • Volume: 0
  • Market Cap: £586.83m
  • RiskGrade: 136
  • Beta: 0.01

CVS performing in line ahead of tougher second half

By Josh White

Date: Friday 07 Feb 2020

LONDON (ShareCast) - (Sharecast News) - Veterinary services provider CVS updated the market on its trading on Friday, reporting that the improved trading performance it delivered in the second half of the year ended 30 June, and the "encouraging start" to the new financial year, had continued for the remainder of the half year to 31 December.
The AIM-traded firm said that In the first half, its total sales increased 15.% and like-for-like sales were up 8.4%, on a year-on-year basis.

Within the group's core practice division, total sales rose 13.7% and practices like-for-like sales were 7.4% higher.

Gross margins for the group in the first half 2020 were 76.0%, compared to 76.2% in the first half of the 2019 financial year.

"This slight reduction primarily results from strong sales growth for Animed Direct, our online dispensary, for which margins are lower and which accounted for 6.3% of group sales in the first half, [up from] 5.3%," the board said in its statement.

Practice division gross margins improved to 78.3% in the period, from 77.8% a year earlier.

"Within the practice division, the growth in total and like-for-like sales and the improvement in gross margin largely reflect the continuing focus on high quality clinical work, including increased volume and value of referrals within the group, and the benefit of modest price increases previously described in our November update."

CVS said employment costs for the group in the first half were 51.0% of total sales, compared to 51.6% 12 months prior.

"This reduction stems from a continued focus on the retention of clinical staff, and the group is pleased to announce that its veterinary surgeon vacancy rate averaged 7.8% in the first half, [down from] 8.7%."

As a result, the company said it expected to report first half adjusted EBITDA that was "materially above" the prior year.

"This is in line with management expectations and is attributed to the better performance in the first half of the 2020 financial year, as well as the weaker comparative in the first half of 2019."

Looking ahead, CVS said the comparatives would become more challenging in the second half of the current financial year, given the improved performance seen in the second half of 2019.

"The continuing positive trends in key performance indicators provide further assurance that the group is trading in line with management's expectations for the full year."

At 1356 GMT, shares in CVS Group were down 1.28% at 1,234p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CVS Group Market Data

Currency UK Pounds
Share Price 818.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,704.00p
52 Week Low 798.00p
Volume 0
Shares Issued 71.74m
Market Cap £586.83m
Beta 0.01
RiskGrade 136

CVS Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average0.07% below the market average
17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average
Price Trend
70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average70.09% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Income
87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average87.25% below the market average
90% below the sector average90% below the sector average90% below the sector average90% below the sector average90% below the sector average
Growth
46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

What The Brokers Say

Strong Buy 4
Buy 4
Neutral 1
Sell 1
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CVS Group Dividends

  Latest Previous
  Final Final
Ex-Div 31-Oct-24 02-Nov-23
Paid 29-Nov-24 08-Dec-23
Amount 8.00p 7.50p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CVS Group Key Personnel

CEO Richard Fairman
Finance Director Robin Alfonso

Top of Page